Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05197790 · ClinicalTrials.gov registry record · NA
Functionality of the Pulse Oximeter and Accelerometer Portions of a Novel Wearable Device
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT05197790: Completed NA study, sponsored by University of Pennsylvania.
NCT05197790 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05197790, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to asses the function of an oxygen sensor and the movement sensor in a novel device prototype.
Interventions
- DEVICE FDA approved pulse oximeter and DOVE device prototype
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2022-05-20 |
| Est. Completion | 2024-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05197790
The ClinicalTrials.gov registry entry for NCT05197790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FDA approved pulse oximeter and DOVE device prototype is the first listed.
NCT05197790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05197790 about?
NCT05197790 is a clinical study titled "Functionality of the Pulse Oximeter and Accelerometer Portions of a Novel Wearable Device". The purpose of this study is to asses the function of an oxygen sensor and the movement sensor in a novel device prototype.
What is the current status of trial NCT05197790?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2022-05-20. Estimated completion is 2024-12-28.
What interventions are being tested in trial NCT05197790?
The interventions under investigation include: FDA approved pulse oximeter and DOVE device prototype (DEVICE).
Who is sponsoring clinical trial NCT05197790?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.